2022
DOI: 10.1080/07391102.2022.2112620
|View full text |Cite
|
Sign up to set email alerts
|

Rational design of 1,2,3-triazole hybrid structures as novel anticancer agents: synthesis, biological evaluation and molecular docking studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 47 publications
0
2
0
Order By: Relevance
“…Indeed, the 1,2,3-Triazole-containing hybrids have been widely demonstrated to have antioxidant and anticancer activities. 2 , 3 , 4 …”
Section: Introductionmentioning
confidence: 99%
“…Indeed, the 1,2,3-Triazole-containing hybrids have been widely demonstrated to have antioxidant and anticancer activities. 2 , 3 , 4 …”
Section: Introductionmentioning
confidence: 99%
“…Several flavonoids with antitumor activity are known in the literature [ 10 , 11 ]. Flavones containing a 2-phenylchromen-4-one ( 1 ) backbone, and 1,2,3-triazole derivatives keep attracting much research interest, and many 1,2,3-triazole-containing hybrids are known as effective anticancer agents [ 12 , 13 , 14 , 15 ]. During the last decade, numerous biologically active flavone—1,2,3-triazole hybrids have been synthesized [ 16 , 17 , 18 ], for example, 5 apigenin-7-methyl ether derivative, which showed promising activity against ovarian cancer ( IC 50 = 10, 15 and 20 µM for SKOV3, OVCAR-3 and Caov-3 cancer cell lines) ( Figure 1 ) [ 19 ].…”
Section: Introductionmentioning
confidence: 99%